Forecast of probable negative effects initiated by transformation of the proteomic profile of human blood plasma under combined exposure to chemicals

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Introduction. The study of the mechanisms of external environmental effects of chemicals on the human body using highly informative proteomic profiling technologies makes it possible to predict the development of negative effects at the earliest stage of their formation. In combination with experimental studies that exclude the influence of interfering factors, the accuracy of identifying changes in the protein profile increases. Assessing the cause-and-effect relationships between exposure to chemicals and protein transformation increases the effectiveness of prognosis and measures to prevent negative consequences.

The purpose of the work is the forecast of probable negative effects initiated by the transformation of the proteomic profile of blood plasma under the combined influence of chemicals, relied upon on bioinformation matrices based on the results of a comparative analysis of natural and experimental studies (using the example of aluminum oxide, hydrogen fluoride, and benzo(a)pyrene).

Materials and methods. Using the methods of chemical-analytical, statistical, proteomic, and bioinformational analysis, molecular-cellular events were identified in 4–7 years children exposed to aerogenic exposure to benzo(a)pyrene, hydrogen fluoride, and aluminum oxide (field studies). During the comparative analysis, the obtained results were verified by data from experimental studies (Wistar rats) subjected to combined and isolated inhalation exposure in doses equivalent to real ones. Identical proteins were identified and a bioinformation matrix was constructed, on the basis of which a forecast of probable negative effects was made using generally accepted metadata databases.

Results. As a result of field studies, in children exposed to benzo(a)pyrene at a level of up to 2.2 MPC.g. (up to 2.2 RfC), aluminum oxide and hydrogen fluoride — up to 0.3 MPC.g. (up to 0.1 RfC), the concentrations of the studied substances in biological media were established to be 2.0–3.6 times higher than the comparison indicators and reference levels. In the experiment, the content of these contaminants in biological media in exposed animals was up to 19.4 times higher than in the control. In children there were identified, 22 proteins corresponding to the library mass spectra, 40 proteins — in animals. In a comparative analysis of proteins identified in the blood plasma in children and rats, Apolipoprotein A-I and Transthyretin were identified and assessed as “identical”. The expression of these proteins elevates with increasing concentration of the studied substances in biological media. According to information from databases, increased expression of Apolipoprotein A-I and Transthyretin signals an higher risk for the oxidative stress, impaired lipid metabolism, and the development of inflammatory processes. The constructed bioinformation matrix made it possible to predict metabolic disorders, mainly in the tissues of the nervous and hepatobiliary systems.

Limitations. The study does not allow drawing definitive conclusions about the effect of the studied chemicals on changes in the expression of proteins and the genes encoding them, since in this work only the aerogenic route of entry is considered.

Conclusion. The transformation of the proteomic profile of blood plasma was established in field studies and experimentally verified during chronic inhalation exposure to aluminum oxide, hydrogen fluoride and benzo(a)pyrene. A comparative analysis of the identified proteins revealed two identical ones — Apolipoprotein A-I and Transthyretin. A bioinformation matrix was constructed and a forecast was made for the development of negative effects in the form of activation of oxidative processes, lipid dysmetabolism and inflammation, the metabolic pathway of which is associated with changes in the expression of these proteins. In the absence of preventive measures, this can lead to the development of atherosclerosis, hypertension, obesity, amyloidosis, hyperthyroidism, etc. in older age. The use of structural bioinformation matrices as a forecasting tool in hygienic research increases the effectiveness of targeted prevention measures for negative consequences due to environmental exposure to chemicals.

Compliance with ethical standards. Experimental studies on a biological model were conducted in compliance with the requirements of the European Convention for the Protection of Vertebrates Used for Experimental or Other Scientific Purposes (ETS No. 123). The examination of children was carried out in compliance with the ethical principles of the Helsinki Declaration (2013). The research was approved by the Committee on Biomedical Ethics of the Federal State Budgetary Institution “FNC MPT URZN” (minutes of meeting No. 1 dated 02/14/2021).

Contribution:
Zaitseva N.V. editing;
Zemlyanova M.A. concept and design of research, editing;
Peskova E.V. concept and design of research, collection of literature data, statistical processing of material, writing of text.
All authors are responsible for the integrity of all parts of the manuscript and approval of the manuscript final version

Conflict of interest. The authors declare the absence of obvious and potential conflicts of interest in connection with the publication of this article.

Acknowledgement. The study was carried out at the expense of the Federal budget.

Received: February 16, 2024 / Revised: March 13, 2024 / Accepted: April 9, 2024 / Published: June 17, 2024

About the authors

Nina V. Zaitseva

Federal Scientific Center for Medical and Preventive Health Risk Management Technologies; Russian Academy of Sciences, Department of Medical Sciences (Section of Preventive Medicine)

Author for correspondence.
Email: znv@fcrisk.ru
ORCID iD: 0000-0003-2356-1145

MD, PhD, Dsci, professor, Academician of the RAS, Scientific Head of the Federal Scientific Center for Medical and Preventive Health Risk Management Technologies, Perm, 614045, Russian Federation; Russian Academy of Sciences, Department of Medical Sciences (Section of Preventive Medicine), Moscow, 119071, Russian Federation

e-mail: znv@fcrisk.ru

Russian Federation

Marina A. Zemlyanova

Federal Scientific Center for Medical and Preventive Health Risk Management Technologies; Perm State National Research University

Email: zem@fcrisk.ru
ORCID iD: 0000-0002-8013-9613

MD, PhD, Dsci., Associate Professor, Head of the Department of biochemical and cytogenetic diagnostic methods of the Federal Scientific Center for Medical and Preventive Health Risk Management Technologies, Perm, 614045, Russian Federation, Perm State National Research University, Perm, 614990, Russian Federation

e-mail: zem@fcrisk.ru

Russian Federation

Ekaterina V. Peskova

Federal Scientific Center for Medical and Preventive Health Risk Management Technologies

Email: peskova@fcrisk.ru
ORCID iD: 0000-0002-8050-3059

Postgraduate student, junior researcher, Department of biochemical and cytogenetic diagnostic methods of the Federal Scientific Center for Medical and Preventive Health Risk Management Technologies, Perm, 614045, Russian Federation

e-mail: peskova@fcrisk.ru

Russian Federation

References

  1. Skinner M.K. Environmental epigenomics and disease susceptibility. EMBO Rep. 2011; 12(7): 620–2. https://doi.org/10.1038/embor.2011.125
  2. Rappaport S.M. Discovering environmental causes of disease. J. Epidemiol. Community Health. 2012; 66(2): 99–102. https://doi.org/10.1136/jech-2011-200726
  3. Cote I., Andersen M.E., Ankley G.T., Barone S., Birnbaum L.S., Boekelheide K., et al. The next generation of risk assessment multi-year study-highlights of findings, applications to risk assessment, and future directions. Environ. Health Perspect. 2016; 124(11): 1671–82. https://doi.org/10.1289/EHP233
  4. Sturla S.J., Boobis A.R., FitzGerald R.E., Hoeng J., Kavlock R.J., Schirmer K., et al. Systems toxicology: from basic research to risk assessment. Chem. Res. Toxicol. 2014; 27(3): 314–29. https://doi.org/10.1021/tx400410s
  5. Brockmeier E.K., Hodges G., Hutchinson T.H., Butler E., Hecker M., Tollefsen K.E., et al. The role of omics in the application of adverse outcome pathways for chemical risk assessment. Toxicol. Sci. 2017; 158(2): 252–62. https://doi.org/10.1093/toxsci/kfx097
  6. Ankley G.T., Bennett R.S., Erickson R.J., Hoff D.J., Hornung M.W., Johnson R.D., et al. Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ. Toxicol. Chem. 2010; 29(3): 730–41. https://doi.org/10.1002/etc.34
  7. Villeneuve D.L., Crump D., Garcia-Reyero N., Hecker M., Hutchinson T.H., LaLone C.A., et al. Adverse outcome pathway (AOP) development I: strategies and principles. Toxicol. Sci. 2014; 142(2): 312–20. https://doi.org/10.1093/toxsci/kfu199
  8. Zaitseva N.V., Zemlyanova M.A., Dolgikh O.V. Genomic, transcriptomic and proteomic technologies as a modern tool for health disorders diagnostics, associated with the impact of environmental factors. Gigiena i Sanitaria (Hygiene and Sanitation, Russian journal). 2020; 99(1): 6–12. https://doi.org/10.33029/0016-9900-2020-99-1-6-12 https://elibrary.ru/pipsea (in Russian)
  9. Anderson N.L., Anderson N.G. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell Proteomics. 2002; 1(11): 845–67. https://doi.org/10.1074/mcp.r200007-mcp200
  10. Corzett T.H., Fodor I.K., Choi M.W., Walsworth V.L., Turteltaub K.W., McCutchen-Maloney S.L., et al. Statistical analysis of variation in the human plasma proteome. J. Biomed. Biotechnol. 2010; 2010: 258494. https://doi.org/10.1155/2010/258494
  11. Hilton I.B., Gersbach C.A. Enabling functional genomics with genome engineering. Genome Res. 2015; 25(10): 1442–55. https://doi.org/10.1101/gr.190124.115
  12. Sosedova L.M., Filippova T.M. The role of biosimulation in human chemical safety system. Ekologiya cheloveka. 2017; (7): 46–52. https://doi.org/10.33396/1728-0869-2017-7-46-52 https://elibrary.ru/yunopd (in Russian)
  13. Tietz N.W. Clinical Guide to Laboratory Tests. W.B. Saunders; 1983.
  14. Glantz S.A. Primer of Biostatistics. New York: McGraw Hill; 1997.
  15. Blum H., Beier H., Gross H.J. Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels. Electrophoresis. 1987; 8(2): 93–9. https://doi.org/10.1002/elps.1150080203
  16. Shevchenko A., Wilm M., Vorm O., Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 1996; 68(5): 850–8. https://doi.org/10.1021/ac950914h
  17. Halley P., Kadakkuzha B.M., Faghihi M.A., Magistri M., Zeier Z., Khorkova O., et al. Regulation of the apolipoprotein gene cluster by a long noncoding RNA. Cell Rep. 2014; 6(1): 222–30. https://doi.org/10.1016/j.celrep.2013.12.015
  18. Cooke A.L., Morris J., Melchior J.T., Street S.E., Jerome W.G., Huang, R., et al. A thumbwheel mechanism for APOA1 activation of LCAT activity in HDL. J. Lipid. Res. 2018; 59(7): 1244–55. https://doi.org/10.1194/jlr.M085332
  19. Guo Q., Zhang C., Wang Y. Overexpression of apolipoprotein A-I alleviates endoplasmic reticulum stress in hepatocytes. Lipids Health Dis. 2017; 16(1): 105. https://doi.org/10.1186/s12944-017-0497-3
  20. Kontush A., Chapman M.J. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol. Rev. 2006; 58(3): 342–74. https://doi.org/10.1124/pr.58.3.1
  21. Tani S., Takahashi A., Nagao K., Hirayama A. Contribution of apolipoprotein A-I to the reduction in high-sensitivity C-reactive protein levels by different statins: comparative study of pitavastatin and atorvastatin. Heart Vessels. 2015; 30(6): 762–70. https://doi.org/10.1007/s00380-014-0554-z
  22. Li X., Buxbaum J.N. Transthyretin and the brain re-visited: is neuronal synthesis of transthyretin protective in Alzheimer’s disease? Mol. Neurodegener. 2011; 6: 79. https://doi.org/10.1186/1750-1326-6-79
  23. Li X., Masliah E., Reixach N., Buxbaum J.N. Neuronal production of transthyretin in human and murine Alzheimer’s disease: is it protective? J. Neurosci. 2011; 31(35): 12483–90. https://doi.org/10.1523/JNEUROSCI.2417-11.2011
  24. Martinho A., Gonçalves I., Costa M., Santos C.R. Stress and glucocorticoids increase transthyretin expression in rat choroid plexus via mineralocorticoid and glucocorticoid receptors. J. Mol. Neurosci. 2012; 48(1): 1–13. https://doi.org/10.1007/s12031-012-9715-7
  25. Wieczorek E., Ożyhar A. Transthyretin: from structural stability to osteoarticular and cardiovascular diseases. Cells. 2021; 10(7): 1768. https://doi.org/10.3390/cells10071768
  26. Navab M., Hama S.Y., Cooke C.J., Anantharamaiah G.M., Chaddha M., Jin L., et al. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. J. Lipid. Res. 2000; 41(9): 1481–94.
  27. Liz M.A., Gomes C.M., Saraiva M.J., Sousa M.M. ApoA-I cleaved by transthyretin has reduced ability to promote cholesterol efflux and increased amyloidogenicity. J. Lipid. Res. 2007; 48(11): 2385–95. https://doi.org/10.1194/jlr.M700158-JLR200
  28. Exley C. Human exposure to aluminium. Environ. Sci. Process Impacts. 2013; 15(10): 1807–16. https://doi.org/10.1039/c3em00374d
  29. Yuan C.Y., Lee Y.J., Hsu G.S. Aluminum overload increases oxidative stress in four functional brain areas of neonatal rats. J. Biomed. Sci. 2012; 19(1): 51. https://doi.org/10.1186/1423-0127-19-51
  30. Guney M., Oral B., Karahan N., Mungan T. Protective effect of caffeic acid phenethyl ester (CAPE) on fluoride-induced oxidative stress and apoptosis in rat endometrium. Environ. Toxicol. Pharmacol. 2007; 24(2): 86–91. https://doi.org/10.1016/j.etap.2007.01.005
  31. Guth S., Hüser S., Roth A., Degen G., Diel P., Edlund K., et al. Toxicity of fluoride: critical evaluation of evidence for human developmental neurotoxicity in epidemiological studies, animal experiments and in vitro analyses. Arch. Toxicol. 2020; 94(5): 1375–415. https://doi.org/10.1007/s00204-020-02725-2
  32. Duan J., Chen C., Li H., Ju G., Gao A., Sun Y., et al. Multifaceted protective effects of hesperidin by aromatic hydrocarbon receptor in endothelial cell injury induced by benzo[a]pyrene. Nutrients. 2022; 14(3): 574. https://doi.org/10.3390/nu14030574
  33. Ranjit S., Midde N.M., Sinha N., Patters B.J., Rahman M.A., Cory T.J., et al. Effect of polyaryl hydrocarbons on cytotoxicity in monocytic cells: potential role of cytochromes P450 and oxidative stress pathways. PLoS One. 2016; 11(9): e0163827. https://doi.org/10.1371/journal.pone.0163827

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2024 Zaitseva N.V., Zemlyanova M.A., Peskova E.V.



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 37884 от 02.10.2009.